Status:
COMPLETED
Evaluating the Impact of a Value-based Prescription Drug Formulary
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Donaghue Medical Research Foundation
Conditions:
Value-Based Health Insurance
Eligibility:
All Genders
Up to 64 years
Brief Summary
The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medi...
Eligibility Criteria
Inclusion
- Individuals:
- aged 0-64
- Continuously enrolled in an employer-sponsored health plan for at least 12 months (with one-month allowable gap) prior to the index date
- For individuals in the exposed group, the index date is defined as the start date of value-based formulary implementation at the employer group level
- For individuals in the control group, the index date is defined as the index date of the matched exposed individual
- Employer groups:
- that transition to the value-based formulary if they transitioned all enrollees in that employer group (no individual selection)
Exclusion
- \- Individuals with:
- missing gender information
- missing zip code level demographics at all member months
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
36333 Patients enrolled
Trial Details
Trial ID
NCT04904055
Start Date
January 1 2015
End Date
December 31 2019
Last Update
May 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente
Seattle, Washington, United States, 98101